RxDoctor Payments Data

Darren di Iulio, DPM

Foot & Ankle Surgery · Newport, KYNPI 1609075720

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 60.4% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $3,317 and has fallen 78.8% since, to $703 in 2025.

$6,860in general payments, 2019–2025

Across 84 payments — averaging $81.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Legacy Ortho LLC$1K
  • Melinta Therapeutics, LLC$256
  • Biotissue Holdings Inc.$164
  • Paragon 28, Inc.$163
  • Integra Lifesciences Corporation$149
  • plus $710 from 20 others

What the payments were for

  • Travel & lodging$2,24733%
  • Food & beverage$3,41350%
  • Education$1,20017%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,860 in reported general payments places this provider in the 70th percentile of 141 foot & ankle surgery providers in Kentucky.

See all foot & ankle surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$138,719
Medicare patients
453
Services billed
5,017

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin24$2,474
Celecoxib17$2,142
Gabapentin99$787
Allopurinol52$684
Ciclopirox22$343
Ketoconazole16$321
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$313
Terbinafine Hcl29$306
Doxycycline Monohydrate26$273
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$138
Clindamycin Hcl13$102
Ammonium Lactate12$73
Mupirocin17$61
Ibuprofen12$37

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Newport

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →